Lanean...
Dyslipidemia causes overestimation of plasma mitotane measurements
Mitotane (o,p′-DDD) is the standard treatment for advanced adrenocortical carcinoma (ACC). Monitoring of plasma mitotane levels is recommended to look for a therapeutic window between 14 and 20mg/L, but its positive predictive value requires optimization. We report the case of an ACC patient with a...
Gorde:
| Argitaratua izan da: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Bioscientifica Ltd
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4901334/ https://ncbi.nlm.nih.gov/pubmed/27298727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-15-0135 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|